Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Here’s how to know which one is a fit for you.

If you've been curious about weight loss medications but feel overwhelmed by all the options, you're not alone. With so many ...

Zepbound and Wegovy treat weight loss and weight management in adults with obesity or overweight. Both drugs are also approved to treat other conditions. These drugs are given as weekly injections, ...

The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers. Here's how it ...

Medically reviewed by Anju Goel, MD Wegovy, Saxenda, and Zepbound are FDA-approved peptides specifically for weight loss.Peptide medications require a prescription and should be taken as a doctor ...

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who've struggled to ...

Zepbound (tirzepatide) is a type of drug called a glucagon-like peptide-1 (GLP-1) receptor agonist. It has the same active ingredient as the type 2 diabetes medication Mounjaro. The Food and Drug ...

Here’s how retatrutide works and how it differs from existing weight management medications.

Insurance may cover Zepbound (tirzepatide) depending on your plan and the specific condition being treated. To determine whether your plan covers Zepbound, contact your insurance provider directly. If ...

Feeling tired or sleepy is a common side effect of Zepbound. Following a nutrient-dense diet and staying physically active may help boost energy levels. Most drug side effects gradually decrease with ...